-transparent.png){kind=logo}
The short-acting opiate antagonist naloxone decreases food intake in three models of ingestive behavior: free feeding, food-deprivation induced feeding and deoxyglucose-induced feeding. Twenty-four hours after administration, the long-acting, mu1 selective antagonist naloxonazine inhibits food intake to the same extent as naloxone in freely feeding and food-deprived rats, but not in animals treated with 2-deoxyglucose. These results indicate that 1) opiates modulate feeding through multiple opioid receptor mechanisms, one of which is the mu subtype, and 2) the feeding observed in various experimental paradigms are modulated by different receptor subtypes. Furthermore, these results illustrate the usefulness of naloxone in defining a behavior as opioid but point out its limitations in discriminating between opioid receptor subtypes.
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
December 1991,
Appetite,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
March 1993,
Physiology & behavior,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
January 1990,
Physiology & behavior,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
January 1983,
Peptides,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
August 1985,
European journal of pharmacology,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
May 1991,
Neuroendocrinology,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
January 1991,
General pharmacology,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
August 2009,
Behavioral neuroscience,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
February 1983,
The Journal of pharmacology and experimental therapeutics,
D A Simone, and
R J Bodnar, and
E J Goldman, and
G W Pasternak
January 1982,
Life sciences,
